JO3037B1 - N -[5-(أمينوسلفونيل)-4- ميثيل-3،1- ثيازول-2- يل]-n- ميثيل-2-[4-(2- بيريدينيل) فنيل] أسيتاميد ميسيلات مونوهيدرات - Google Patents

N -[5-(أمينوسلفونيل)-4- ميثيل-3،1- ثيازول-2- يل]-n- ميثيل-2-[4-(2- بيريدينيل) فنيل] أسيتاميد ميسيلات مونوهيدرات

Info

Publication number
JO3037B1
JO3037B1 JOP/2012/0276A JOP20120276A JO3037B1 JO 3037 B1 JO3037 B1 JO 3037B1 JO P20120276 A JOP20120276 A JO P20120276A JO 3037 B1 JO3037 B1 JO 3037B1
Authority
JO
Jordan
Prior art keywords
methyl
aminosulfonyl
thiazol
pyridinyl
phenyl
Prior art date
Application number
JOP/2012/0276A
Other languages
English (en)
Inventor
Wilfried Schwab
Alfons Grunenberg
Alexander Birkmann
Andreas Lender
Birgit D -I Keil
Joachim Rehse
Dieter Haag
Kurt Vögtli
Original Assignee
Aicuris Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aicuris Gmbh & Co Kg filed Critical Aicuris Gmbh & Co Kg
Application granted granted Critical
Publication of JO3037B1 publication Critical patent/JO3037B1/ar

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

يتعلق الاختراع الحالي بتخليق محسن وقصير من N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide وملح mesylate monohydrate منه باستخدام مشتقات boronic acid أو عوامل كاشفة borolane بينما يتم تجنب مركبات tin عضوية سامة وبملح mesylate monohydrate من N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acet-amide الذي يظهر زيادة الثبات طويل الأجل وإطلاق حركيات من التركيبات الدوائية.
JOP/2012/0276A 2011-09-26 2012-09-23 N -[5-(أمينوسلفونيل)-4- ميثيل-3،1- ثيازول-2- يل]-n- ميثيل-2-[4-(2- بيريدينيل) فنيل] أسيتاميد ميسيلات مونوهيدرات JO3037B1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11007823A EP2573086A1 (en) 2011-09-26 2011-09-26 N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate

Publications (1)

Publication Number Publication Date
JO3037B1 true JO3037B1 (ar) 2016-09-05

Family

ID=46889067

Family Applications (2)

Application Number Title Priority Date Filing Date
JOP/2012/0276A JO3037B1 (ar) 2011-09-26 2012-09-23 N -[5-(أمينوسلفونيل)-4- ميثيل-3،1- ثيازول-2- يل]-n- ميثيل-2-[4-(2- بيريدينيل) فنيل] أسيتاميد ميسيلات مونوهيدرات
JOP/2016/0114A JO3734B1 (ar) 2011-09-26 2016-06-07 -n[5-(أمينوسلفونيل)-4- ميثيل-3،1- ثيازول-2- يل]-n- ميثيل-2-[4-(2- بيريدينيل) فنيل] أسيتاميد ميسيلات مونوهيدرات

Family Applications After (1)

Application Number Title Priority Date Filing Date
JOP/2016/0114A JO3734B1 (ar) 2011-09-26 2016-06-07 -n[5-(أمينوسلفونيل)-4- ميثيل-3،1- ثيازول-2- يل]-n- ميثيل-2-[4-(2- بيريدينيل) فنيل] أسيتاميد ميسيلات مونوهيدرات

Country Status (29)

Country Link
US (1) US9340535B2 (ar)
EP (3) EP2573086A1 (ar)
JP (2) JP6161614B2 (ar)
KR (4) KR101768295B1 (ar)
CN (2) CN103842359B (ar)
AR (3) AR088043A1 (ar)
AU (2) AU2012314536B2 (ar)
BR (1) BR112014003245B1 (ar)
CA (1) CA2791142C (ar)
CL (1) CL2014000149A1 (ar)
DK (2) DK2598501T3 (ar)
ES (2) ES2462492T3 (ar)
HK (1) HK1220978A1 (ar)
HR (1) HRP20140351T1 (ar)
IL (2) IL230152A (ar)
IN (1) IN2014DN01993A (ar)
JO (2) JO3037B1 (ar)
MX (2) MX371088B (ar)
MY (2) MY185063A (ar)
PE (1) PE20141148A1 (ar)
PH (1) PH12015502801A1 (ar)
PL (2) PL2598501T3 (ar)
PT (1) PT2598501E (ar)
RU (2) RU2620604C2 (ar)
SG (1) SG10201407430TA (ar)
TW (2) TWI567070B (ar)
UA (2) UA119574C2 (ar)
WO (1) WO2013045479A1 (ar)
ZA (2) ZA201401773B (ar)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2573086A1 (en) * 2011-09-26 2013-03-27 AiCuris GmbH & Co. KG N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate
EP2573085A1 (en) * 2011-09-26 2013-03-27 AiCuris GmbH & Co. KG N-[5-(aminosulfonyl)-4methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl] acetamide mesylate monohydrate having a specific particle size distribution range and a specific surface area range
PE20181804A1 (es) * 2016-04-06 2018-11-19 Innovative Molecules Gmbh Derivados de aminotiazol utiles como agentes antiviricos
PL3544977T3 (pl) * 2016-11-28 2021-11-08 Aicuris Gmbh & Co. Kg Sól maleinianowa wolnej zasady n-[5-(aminosulfonylo)-4-metylo-1,3-tiazol-2-ilo]-n-metylo-2-[4-(2-pirydynylo)fe¬nylo]acetamidu, preparaty farmaceutyczne, sposoby wytwarzania oraz ich zastosowania do leczenia wirusa opryszczki
TW201825095A (zh) * 2016-11-28 2018-07-16 德商艾庫里斯抗感染治療有限公司 包含n-[5-(胺基磺醯基)-4-甲基-1,3-噻唑-2-基]-n-甲基-2-[4-(2-吡啶基)-苯基]-乙醯胺之局部醫藥調配物
AU2017365632B2 (en) * 2016-11-28 2021-07-15 Aicuris Gmbh & Co. Kg N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof
KR102335327B1 (ko) 2017-04-28 2021-12-03 현대자동차 주식회사 수냉식 이지알 쿨러
DK3644958T3 (da) * 2017-06-28 2021-10-25 Aicuris Gmbh & Co Kg Intravaginalt anvendelige indretninger omfattende antivirale forbindelser
SI3692039T1 (sl) 2017-10-05 2023-04-28 Innovative Molecules Gmbh Enantomeri substituiranih tiazolov kot protivirusne spojine
JP7150368B2 (ja) * 2018-07-06 2022-10-11 フェーノ・セラピューティクス・カンパニー・リミテッド チアゾール系化合物の結晶形およびその応用
JP2022500543A (ja) * 2018-09-19 2022-01-04 モデルナティーエックス, インコーポレイテッド 高純度peg脂質及びそれらの使用
TW202038947A (zh) 2018-11-28 2020-11-01 德商創新分子有限責任公司 在與溶瘤病毒之組合療法中治療癌症的解旋酶引子酶抑制劑
WO2024047506A1 (en) 2022-08-29 2024-03-07 Assembly Biosciences, Inc. A novel crystalline form of pritelivir
WO2024047507A1 (en) 2022-08-29 2024-03-07 Assembly Biosciences, Inc. A novel crystalline form of pritelivir
WO2024047508A1 (en) 2022-08-29 2024-03-07 Assembly Biosciences, Inc. Pharmaceutical compositions for herpes virus

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DOP2000000109A (es) 1999-12-23 2002-08-30 Gerald Kleymann Derivados de tiazolilamida
DE10129716A1 (de) * 2001-06-22 2003-01-02 Bayer Ag Kombinationspräparate zur Herpes-Behandlung
DE10129717A1 (de) * 2001-06-22 2003-01-02 Bayer Ag Kombinationspräparate zur Herpes-Behandlung
DE10129714A1 (de) * 2001-06-22 2003-01-02 Bayer Ag Topische Anwendung von Thiazolylamiden
DE10131128A1 (de) * 2001-06-28 2003-01-16 Bayer Ag Sekundäre Sulfonamide
GB0423653D0 (en) * 2004-10-25 2004-11-24 Piramed Ltd Pharmaceutical compounds
DE102005014248A1 (de) * 2005-03-30 2006-10-05 Aicuris Gmbh & Co. Kg Pharmazeutische Zubereitung von N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamid
JP2007314516A (ja) * 2006-04-25 2007-12-06 Daiichi Sankyo Co Ltd 2以上の置換基を有するベンゼン化合物を含有する医薬
EA201200423A1 (ru) * 2006-06-09 2012-08-30 Икос Корпорейшн Замещенные фенилуксусные кислоты как dp-2-антагонисты
AR070127A1 (es) * 2008-01-11 2010-03-17 Novartis Ag Pirrolo - pirimidinas y pirrolo -piridinas
UA103918C2 (en) * 2009-03-02 2013-12-10 Айерем Элелси N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
EP2573086A1 (en) * 2011-09-26 2013-03-27 AiCuris GmbH & Co. KG N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate
EP2573085A1 (en) * 2011-09-26 2013-03-27 AiCuris GmbH & Co. KG N-[5-(aminosulfonyl)-4methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl] acetamide mesylate monohydrate having a specific particle size distribution range and a specific surface area range

Also Published As

Publication number Publication date
CN105541829A (zh) 2016-05-04
KR101768295B1 (ko) 2017-08-14
DK2598501T3 (da) 2014-04-22
AR088043A1 (es) 2014-05-07
MY190878A (en) 2022-05-13
MX2014003389A (es) 2014-07-09
WO2013045479A1 (en) 2013-04-04
PL2598501T3 (pl) 2014-08-29
KR20140066704A (ko) 2014-06-02
ZA201401773B (en) 2015-12-23
JP2014528948A (ja) 2014-10-30
PH12015502801B1 (en) 2016-10-03
RU2014107430A (ru) 2015-11-10
MX371088B (es) 2020-01-16
RU2669388C1 (ru) 2018-10-11
IL230152A (en) 2015-04-30
TW201317234A (zh) 2013-05-01
SG10201407430TA (en) 2014-12-30
UA119574C2 (uk) 2019-07-10
JP6353022B2 (ja) 2018-07-04
EP2573086A1 (en) 2013-03-27
CA2791142C (en) 2017-08-01
AR120291A2 (es) 2022-02-09
AU2012314536A1 (en) 2014-02-06
PH12015502801A1 (en) 2016-10-03
BR112014003245A2 (pt) 2017-03-01
AR116394A2 (es) 2021-05-05
KR20180088530A (ko) 2018-08-03
HRP20140351T1 (hr) 2014-07-04
ES2466221T8 (es) 2016-09-13
NZ718867A (en) 2016-05-27
TW201625603A (zh) 2016-07-16
AU2015260762B2 (en) 2016-06-09
JP2017114859A (ja) 2017-06-29
CN103842359A (zh) 2014-06-04
MY185063A (en) 2021-04-30
AU2015260762A1 (en) 2016-02-04
ES2466221T3 (es) 2014-06-09
CN103842359B (zh) 2016-05-25
PL2602258T3 (pl) 2014-08-29
IN2014DN01993A (ar) 2015-05-15
AU2012314536B2 (en) 2016-01-14
US20140221433A1 (en) 2014-08-07
US9340535B2 (en) 2016-05-17
ZA201408734B (en) 2016-08-31
ES2462492T3 (es) 2014-05-23
EP2598501A1 (en) 2013-06-05
NZ621615A (en) 2016-04-29
CA2791142A1 (en) 2013-03-26
EP2602258A1 (en) 2013-06-12
JP6161614B2 (ja) 2017-07-12
DK2602258T3 (da) 2014-04-22
CL2014000149A1 (es) 2014-09-05
PT2598501E (pt) 2014-06-25
RU2620604C2 (ru) 2017-05-29
EP2602258B8 (en) 2016-09-28
KR20190104249A (ko) 2019-09-06
EP2602258B1 (en) 2014-03-19
KR20170055565A (ko) 2017-05-19
MX338736B (es) 2016-04-29
EP2598501B1 (en) 2014-03-12
HK1220978A1 (zh) 2017-05-19
IL234405A (en) 2015-04-30
TWI532739B (zh) 2016-05-11
PE20141148A1 (es) 2014-09-15
TWI567070B (zh) 2017-01-21
BR112014003245B1 (pt) 2021-11-09
UA115317C2 (uk) 2017-10-25
JO3734B1 (ar) 2021-01-31

Similar Documents

Publication Publication Date Title
JO3734B1 (ar) -n[5-(أمينوسلفونيل)-4- ميثيل-3،1- ثيازول-2- يل]-n- ميثيل-2-[4-(2- بيريدينيل) فنيل] أسيتاميد ميسيلات مونوهيدرات
MX2014003623A (es) Monohidrato de mesilato de n-[5-(aminosulfonil)-4-metil-1,3-tiazol -2-il]-2-[4-(2-piridinil)-fenil]-n-metilacetamida con un intervalo de distribucion de tamaño de particula especifica y un intervalo de area superficial especifica para uso en formulaciones farmaceuticas.
MX343753B (es) Inhibidores de neprilisina.
MX342212B (es) Inhibidores de neprilisina.
PE20140831A1 (es) Nuevo derivado de 1,2,3,4-tetrahidroquinolina util para el tratamiento de diabetes
EA201492287A1 (ru) Дейтерированные производные руксолитиниба
MX348654B (es) Composicion farmaceutica con biodisponibilidad mejorada para compuesto hidrofobico de alto punto de fusion.
EA201291217A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ПРОИЗВОДНЫЕ 1-(β-D-ГЛЮКОПИРАНОЗИЛ)-2-ТИЕНИЛМЕТИЛБЕНЗОЛА КАК ИНГИБИТОРЫ НЗПГ
EA201590205A1 (ru) N-алкил 2-(дизамещенные)алкиниладенозин-5-уронамиды в качестве а-агонистов
MX2016009760A (es) Inhibidores de neprilisina.
PH12015501941A1 (en) Benzo-fused heterocyclic derivatives useful as agonists of gpr120
TN2014000166A1 (en) N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics
PE20141993A1 (es) Compuestos de benzotiazolona
WO2014049612A3 (en) Processes and polymorphs of 5-[4-[4-(5-cyano-1h-indol-3-yl) butyl]-1-piperazinyl]-2-benzofuran carboxamide and its salts
CY1119984T1 (el) Σταθεροποιημενη αμορφη μορφη αγομελατινης, μια μεθοδος για την παρασκευη της και φαρμακευτικες συνθεσεις που την περιεχουν
UA116877C2 (uk) Сполука з антибактеріальною і/абопротивірусною активністю
MY162537A (en) dihydro-oxazolobenzodiazepinone derivatives, processes for their preparation and pharmaceutical compositions comprising these compounds
EA201590452A1 (ru) СОЛИ СОЕДИНЕНИЯ БЕНЗОТИАЗОЛОНА В КАЧЕСТВЕ АГОНИСТОВ β-2-АДРЕНОРЕЦЕПТОРОВ
TH147870A (th) การสังเคราะห์แบบปรับปรุงของ n-[5-(อะมิโนซัลโฟนิล)-4-เมทิล-1,3-ไทอะโซล-2-อิล]-n-เมทิล-2-[4-(2-ไพริดินิล)ฟีนิล]อะเซตะไมด์ เมซิเลต โมโนไฮเดรต
PT2602258E (pt) Monohidrato de mesilato de n-[5-aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)fenil]acetamida
UA41094U (en) Derivatives of 4-(bromomethyl)-2-r-1,3-thiazol-3-ium bromides and 4-bromomethyl-2-r-1,3-thiazoles